Skip to main content
OpenTrials

Clinical trial condition

Assess the Efficacy and Safety of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed DLBCL

Explore clinical trials studying Assess the Efficacy and Safety of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed DLBCL. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Assess the Efficacy and Safety of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed DLBCL trial results

Completed

Phase III Study of SyB L-0501 in Combination With Rituximab to Treat Recurrent/Relapsed Diffuse Large B-Cell Lymphoma

NCT03372837

Conditions
Assess the Efficacy and Safety of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed DLBCL, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Research Site Nagoya, Aichi-ken, Japan
  • Research Site Toyoake, Aichi-ken, Japan
  • Research Site Matsuyama, Ehime, Japan
  • Research Site Maebashi, Gunma, Japan
View all 29 locations
View Trial Details

Related conditions